Cite
HARVARD Citation
Dodick, D. et al. (2020). Eptinezumab Demonstrated Efficacy in Sustained Prevention of Episodic and Chronic Migraine Beginning on Day 1 After Dosing. Headache. 60 (10), pp. 2220-2231. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Dodick, D. et al. (2020). Eptinezumab Demonstrated Efficacy in Sustained Prevention of Episodic and Chronic Migraine Beginning on Day 1 After Dosing. Headache. 60 (10), pp. 2220-2231. [Online].